FOXC2 and carcinoma: To understand the clinical implications of the β-catenin/FOXC2 signaling pathway, we examined the EMTome, a public resource for cancer dataset analysis, to assess the correlation between FOXC2 and β-catenin in cancer patients across various carcinoma types [39].